LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

已完结 10 由钱钱发布于 2025/4/22 9:42:54

DOI:10.1016/j.cmet.2022.07.013
作者：Tamer Coskun, Shweta Urva, William C Roell, Hongchang Qu, Corina Loghin, Julie S Moyers, Libbey S O'Farrell, Daniel A Briere, Kyle W Sloop, Melissa K Thoma
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：With an increasing prevalence of obesity, there is a need for new therapies to improve body weight management and metabolic health. Multireceptor agonists in development may provide approach

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:MDPIChitosan-based (Nano)materials for Novel Biomedical Applications.